Package 0071-0007-24

{"route": ["ORAL"], "spl_id": "470b61a6-09e1-45d0-8b65-b77cec9ba9c3", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000191266", "N0000187064", "N0000187063", "N0000185607", "N0000191267", "N0000190118", "N0000185507"], "upc": ["0300710007246"], "unii": ["6158TKW0C5"], "rxcui": ["1313885", "1313887"], "spl_set_id": ["ca119a89-2394-4d34-8078-cd1fa4e8e2f1"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (0071-0007-24)", "package_ndc": "0071-0007-24", "marketing_start_date": "19790226"}], "brand_name": "Dilantin Infatabs", "product_id": "0071-0007_470b61a6-09e1-45d0-8b65-b77cec9ba9c3", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-0007", "generic_name": "Phenytoin", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dilantin Infatabs", "active_ingredients": [{"name": "PHENYTOIN", "strength": "50 mg/1"}], "application_number": "ANDA084427", "marketing_category": "ANDA", "marketing_start_date": "19790226", "listing_expiration_date": "20271231"}